It is with great regret that, after lengthy deliberation and considering all information currently available to us, the Board and Executive of the European Association of Urology have to announce the cancellation of the 35th Annual EAU Congress July, 17 – 21, 2020. Since public health safety measures in relation to COVID-19 are now extended worldwide, […]
We are facing challenging times where healthcare professionals are on the front line of a health crisis. We at the EAU are aware that priorities lie elsewhere at the moment, but this is precisely the moment that we want to be at your side. Today, we publish the new EAU Guidelines which are now available […]
Below, you will find the ERUS Guidelines on dealing with robotic surgery during COVID-19 Pandemic. Due to time constraints, a rigorous review process has not been possible. These guidelines are the results of the scientific evidence present and are to be seen as a consensus of taking in account that all should be done to […]
{{header-clinical-trials-navigation}} A Study to Evaluate the Safety and Efficacy of IMMU-132 (Sacituzumab Govitecan) in Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Progressed on Second Generation AR-Directed Therapy Condition: Prostate Cancer Study Type: Interventional Clinical Trials Identifier NCT 8-digits: NCT03725761 Sponsor: University of Wisconsin, Madison Phase: Phase 2 Eligibility: Age: minimum 18 Years maximum N/A […]
{{header-clinical-trials-navigation}} ESCALATE, A Phase III Randomized Study Comparing Enzalutamide or Darolutamide With Radium-223 vs Enzalutamide or Darolutamide With Placebo and the Effect Upon Symptomatic Skeletal Event-Free Survival for mCRPC Patients Condition: Metastatic Castration-resistant Prostate Cancer Study Type: Interventional Clinical Trials Identifier NCT 8-digits: NCT04237584 Sponsor: MANA RBM Phase: Phase 3 Eligibility: Age: minimum 18 Years […]
{{header-clinical-trials-navigation}} Determination of the Diagnostic Detection Rate of Axumin (Fluciclovine) PET/CT Utilizing the High Resolution Digital Philips Vereos Scanner, in Patients With Biochemical Recurrence After Radical Prostatectomy Condition: Prostatic Neoplasm Study Type: Observational Clinical Trials Identifier NCT 8-digits: NCT04234399 Sponsor: University of Vermont Phase: Eligibility: Age: minimum 40 Years maximum N/A Gender: Male Inclusion Criteria: […]
In this study,1 we first identified a set of 4 genes (TMPRSS11E, SCEL, KRT78, TMEM185A) that were significantly associated with poor overall survival of bladder cancer patients, some of which have not been investigated in urinary bladder cancer before. Compared with previous studies related to disease diagnosis only, our study focused on direct overall survival […]
Retroperitoneal lymph node dissection (RPLND) is a standard treatment in the management of metastatic testicular cancer. Due to modified treatment algorithms, it is becoming less frequent. We analyzed data from the nationwide German hospital billing database covering 2006-2015.
To address information overload for trainees, a concise electronic case-based urology learning program (CBULP) was developed. Previous qualitative assessments suggested CBULP’s potential efficacy/utility.
Advances in systemic targeted therapies afford treatment opportunities in patients with metastatic renal cell carcinoma (RCC). Elderly patients with metastatic RCC present a subpopulation for consideration owing to competing causes of mortality and benefits seen with new therapeutic agents.
